CFFGY - CLINDAMYCIN PHOSPHATE INJECTION,USP,4051

Product Identification

Product ID:CLINDAMYCIN PHOSPHATE INJECTION,USP,4051
MSDS Date:06/21/1996
FSC:6505
NIIN:01-177-1982
MSDS Number: CFFGY

Responsible Party
ABBOTT LABORATORIES,HOSPITAL PRODUCTS DIV
200 ABBOTT PARK RD
ABBOTT PARK, IL 60064-3537
US

Emergency Phone: 847-937-7970/800-424-9300(CHEMTREC)

Info Phone: 708-937-6100

Preparer: FM

Cage: 60060

Contractor
ABBOTT LABORATORIES INC
NORTH CHICAGO, IL 60064 US

Telephone: 847-935-7177

Cage: 60060

Ingredients

CLINDAMYCIN-2-PHOSPHATE

CAS: 24729-96-2

RTECS: GF2625000

Hazards

LD50 LC50 Mixture:LD50 (ORAL, RAT) 1832-2539 MG/KG
Routes of Entry: Inhalation:NO Skin:NO Ingestion:NO
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:TARGET ORGANS:GASTROINTESTINAL TRACT &
POSSIBLY SKIN. ACUTE- THIS PRODUCT IS INTENDED FOR THE TREATMENT OF
SERIOUS INFECTION WHEN PRESCRIBED BY A PHYSICIAN. THE ACTIVE
INGREDIENT MAY CAUSE SKIN RASH O R ALLERGIC REACTION UPON
INGESTION. MAYCAUSE GASTROINTESTINAL TRACT IRRITATION. CHRONIC-
UNKNOWN.
Explanation of Carcinogenicity:NONE
Effects of Overexposure:CLINICAL USE OF CLINDAMYCIN HAS BEEN ASSOCIATED
WITH RASHES, COLITIS (DIARRHEA, ABDOMINAL CRAMPS) AND IRRITANT
RESPONSE.
Medical Cond Aggravated by Exposure:UNKNOWN. THOSE WITH EYE, SKIN OR
RESPIRATORY LESIONS, PRE-EXISTING GASTROINTESTINAL DISTRESS OR
HYPERSENISTIVITY TO CLINDAMYCIN OR RELATED ANTIBIOTICS (E.G.,
LINCOMYCIN) SHOULD AVOID CONTACT.

First Aid

First Aid:CALL A DOCTOR IF SYMPTOMS PERSIST. EYE:FLUSH WITH WATER FOR
15 MINUTES, HOLDING EYELIDS OPEN. SKIN:FLUSH WITH PLENTY OF WATER.
INHALED:REMOVE TO FRESH AIR. ORAL:IF CONSCIOUS, RINSE OUT MOUTH
WITH WATE R. CALL A PHYSICIAN/POISON CONTROL CENTER.

Fire Fighting

Flash Point:NONE
Lower Limits:NOT RELEVANT
Upper Limits:NOT RELEVANT
Extinguishing Media:WATER SPRAY, CARBON DIOXIDE, FOAM OR DRY CHEMICAL
FOR SURROUNDING FIRE. USE WATER SPRAY TO COOL FIRE EXPOSED
CONTAINERS.
Fire Fighting Procedures:WEAR PROTECTIVE CLOTHING AND NIOSH-APPROVED
SELF-CONTAINED BREATHING APPARATUS.

Accidental Release

Spill Release Procedures:ABSORB SPILL WITH VERMICULITE OR OTHER INERT
MATERIAL. PLACE IN A CONTAINER FOR DISPOSAL. CLEAN AREA WITH SOAP
AND PLENTY OF WATER.
Neutralizing Agent:NOT RELEVANT

Handling

Handling and Storage Precautions:STORE AT CONTROLLED ROOM TEMPERATURE
OF 15-30C (59-86F). DO NOT FREEEZE. KEEP OUT OF REACH OF CHILDREN.
Other Precautions:AS A GENERAL RULE, WHEN HANDLING PHARMACEUTICAL
PRODUCTS, AVOID ALL FORMS OF CONTACT AND INHALATION OF DUST, FUMES,
MISTS, AND/OR VAPORS ASSOCIATED WITH THE PRODUCT. WASH THOROUGHLY
AFTER HANDLING AND BEFORE EATING OR DRINKING.

Exposure Controls

Respiratory Protection:NONE SHOULD BE NEEDED.
Ventilation:NO SPECIAL PROVISIONS ARE REQUIRED UNDER NORMAL PRODUCT
USE.
Protective Gloves:LATEX/RUBBER IF CONTACT POSSIBLE
Eye Protection:SAFETY GLASSES IF CONTACT POSSIBLE
Other Protective Equipment:EYE WASH STATION, LAB COAT
Work Hygienic Practices:OBSERVE GOOD PERSONAL HYGIENE PRACTICES AND
RECOMMENDED PROCEDURES. DO NOT WEAR CONTAMINATED CLOTHING.
Supplemental Safety and Health

Chemical Properties

HCC:N1
NRC/State Lic Num:NOT RELEVANT
Spec Gravity:1.0725
pH:5.5- 7
Viscosity:2.69 CPS @77F
Solubility in Water:SOLUBLE
Appearance and Odor:CLEAR, COLORLESS TO SLIGHT YELLOW SOLUTION

Stability

Hazardous Decomposition Products:MAY EMIT TOXIC FUMES.

Disposal

Waste Disposal Methods:DISPOSE OF IN ACCORDANCE WITH LOCAL, STATE AND
FEDERAL REGULATIONS. RECOMMENDED METHOD IS BY INCINERATION,
RECYCLING OR REUSE.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.